XML 88 R43.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Financial Information (Parent Company Only) (Tables)
12 Months Ended
Dec. 31, 2019
Condensed Financial Information (Parent Company Only)  
Schedule of Condensed Balance Sheet

CONDENSED BALANCE SHEET

DECEMBER 31, 2019

 

(in thousands)

 

 

 

 

 

Assets:

 

 

 

Cash in Bank

 

$

5,392

Due from Subsidiary

 

 

 4

Investment in Subsidiary

 

 

18,920

Total Assets

 

$

24,316

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

Liabilities

 

$

32

Shareholders' Equity

 

 

24,284

Liabilities and Shareholders' Equity

 

$

24,316

 

Schedule of Condensed Statement of Loss

CONDENSED STATEMENT OF LOSS

FOR THE YEAR ENDED DECEMBER 31, 2019

 

(in thousands)

 

 

 

 

 

Income:

    

 

 

Equity in Net Income of Subsidiary

 

$

(22)

Other Income

 

 

27

Total Income

 

 

 5

 

 

 

 

Expenses:

 

 

 

Professional Fees

 

 

85

Other Expense

 

 

48

Total Expense

 

 

133

Loss Before Income Taxes

 

 

(128)

Income Taxes

 

 

 —

Net Loss

 

$

(128)

 

Schedule of Condensed Statement of Cash Flow

 

 

 

 

Cash Flows from Operating Activities:

 

 

  

Net Loss

 

$

(128)

Adjustments to Reconcile Net Loss to Net Cash (Used in) Operating Activities:

 

 

  

Cash (Used in) Operating Activities:

 

 

 

(Increase) in Due from Subsidiary

 

 

(4)

Non-cash Compensation for ESOP

 

 

56

Decrease in Equity in Net Income of Subsidiary

 

 

22

Increase in Liabilities

 

 

32

Net Cash (Used in) Operating Activities

 

 

(22)

 

 

 

 

Cash Flows from Investing Activities:

 

 

  

Investment in Subsidiary

 

 

(6,558)

Net Cash (Used in) Investing Activities

 

 

(6,558)

 

 

 

 

Cash Flows from Financing Activities:

 

 

  

Proceeds from Stock Offering

 

 

11,972

Net Cash Provided by Financing Activities

 

 

11,972

Net Increase in Cash and Cash Equivalents

 

 

5,392

 

 

 

 

Cash and Cash Equivalents at Beginning of Period

 

 

 —

Cash and Cash Equivalents at End of Period

 

$

5,392